Background
==========

Autism Spectrum Disorders (ASD, MIM209850) are a severe neuropsychiatric disorders, primarily characterized by abnormalities in social behavior, communication and language, with patterns of restricted and repetitive interests \[[@B1]\]. Commonly associated symptoms include aggressive and self-injurious behaviors, anxiety, heightened sensitivity to stimuli, and seizures \[[@B2],[@B3]\]. Severity of symptoms in ASD can vary widely among cases, from individuals with mental retardation and no language production to relatively high-functioning individuals with normal to superior intelligence but significant difficulties with social interaction \[[@B4]-[@B6]\].

Multiple lines of evidence converge to suggest that ASDs represent the most heritable neurodevelopmental and psychiatric conditions. Evidence from twin and family studies suggests that the rate of autism in siblings of affected individuals is 2-6% \[[@B7]\], with 92% concordance of ASD in monozygotic twins and over 10% concordance in dizygotic twins \[[@B8]\]. Previous linkage and candidate gene studies have identified several chromosomal regions with autism susceptibility loci \[[@B3],[@B9]-[@B13]\]. A recent study identified a common genetic risk factor underlying ASD employing a genome-wide association strategy in 780 families (3,101 subjects) with affected children, and a second cohort of 1,204 affected subjects and 6,491 control subjects; these findings were replicated in an independent study cohort of 483 ASD families \[[@B14]\]. Furthermore, substantial progress towards the identification of genetic risk variants has come from recent characterization of structural variation (*i.e.*, copy number variation or CNV). Studies of CNVs in a cohort of 859 ASD cases and 1,400 healthy control children revealed structural variants in previously reported ASD candidate genes (*NRXN1*and *CNTNAP4*) and in multiple novel susceptibility genes encoding cell-adhesion molecules, including *NLGN1*and *ASTN2*. Furthermore, CNVs observed in cases but not controls were found within and surroundings genes involved in the ubiquitin pathway (*UBE3A*, *PARK2*, *RFWD2*and *FBXO40*) \[[@B15]\]. In a related study, we performed high-density genotyping and obtained data on 3,832 individuals from 912 multiplex ASD families in the Autism Genetic Research Exchange (AGRE) and 1,489 unrelated control subjects. Through prioritization of exonic deletions (eDels), we recovered genes in which structural variants were present in multiple unrelated probands but not unrelated controls. The 42 genes identified by this method include *NRXN1*, *UBE3A, MADCAM1*and *BZRAP1*\[[@B16]\]. Studies of large families with shared ancestry have reported several other autism loci including large, inherited, homozygous deletions in neuronal cell-adhesion genes, for example *PCDH10*(protocadherin 10) \[[@B17]\]. These findings highlight the utility of \"homozygosity mapping\" and a need to search for additional large families across diverse populations.

Based on these breakthroughs and lessons learned from studies of other complex diseases (i.e. diabetes and breast cancer), it is becoming apparent that there is a need to assess large sample collections that number in the tens of thousands. Population structure poses a challenge for large-scale disease-association studies; mismatched ancestry between cases and controls in a genome-wide association studies is a potential source of spurious associations \[[@B17]\]. These needs and challenges bring together usually separated fields of genetics, epidemiology and studies of human diversity. Also, it is important to relate genetic findings found in patients from developed countries to the studies of diverse populations in less developed parts of the world. Currently DNA has been assembled from only a few thousand individuals with autism worldwide. Significant advances in genetic analyses of ASD in diverse populations will require the collection of samples across many populations using rapid and affordable screening and diagnostic tools.

Isolated populations have contributed to the discovery of genetic factors for many Mendelian disorders \[[@B18]\]. It has been argued that isolated populations may facilitate the identification of susceptibility loci for complex diseases because of a reduced genetic diversity, i.e. reduced genetic heterogeneity \[[@B19],[@B20]\]. Although several Croatian island populations have been described as genetic isolates, the Croatian population as a whole does not represent a population isolate as conventionally defined \[[@B21],[@B22]\]. However, Croatia is a small country with a low migration rate, in which large extended families often live in the same household or same neighbourhood and, therefore, is perfectly suited for family-based genetic studies. We expect that a subset of affected individuals may segregate a limited number of causative ASD susceptibility alleles (causal variants); in some cases these loci or disease-associated haplotypes identified in genetic isolates may differ from those in more genetically diverse populations, such as Europeans in North America. We also expect that a subset of rare variants associated with ASD susceptibility (SNPs and CNVs), which were identified in a large set of Europeans from North America, may be more prevalent in specific ethnic groups like the Croats. Therefore, to improve our understanding of global patterns of human genetic variation and set the stage for large-scale disease studies, efforts are underway to evaluate genetic variation using high-density genotype data for human populations worldwide \[[@B23]-[@B25]\].

With the intention to use the Croatian population in future genome-wide association studies, we performed a genome-wide high-density genotype pilot study of 103 ASD cases and 203 control samples to characterize the genetic structure of the population. Our analysis focuses on (1) the genetic diversity of the Croatian population, and its relationship to other populations, (2) the degree of relatedness of the population through the analysis of Runs of Homozygosity (ROHs), and (3) the distribution of large (\>500 Kb) copy number variations, a major mechanism for structural variation in human genomes, and its possible association with ASD.

Results and Discussion
======================

To understand the complexities of genomic architecture of ASDs, a highly heterogeneous group of disorders, and to assess the distribution and specificity of common and rare variants in different populations, we initiated genomic analysis of ASD and control subjects from Croatia. This cohort, consisting of 103 subjects (children and adults) with ASD and 203 adult control subjects, with male-to-female ratios of 3.7:1 (in ASD) and 2.6:1 (in controls), was originally recruited to study the role of hyperserotonemia in autism \[[@B26]-[@B28]\]. Patients with autism were evaluated by a child psychiatrist and diagnoses were based on DSM-IV-TR \[[@B29]\] criteria. Severity of behavioral symptoms was measured using the Childhood Autism Rating Scale (CARS) \[[@B30]\]. The degree of mental retardation (MR) was assessed according to the standardized intelligence or developmental tests, corresponding to the apparent developmental level of each individual. ASD in selected families occurs either in the absence of positive family history (sporadic) or in families with a high prevalence of other clinical psychiatric disorders distinct from ASD (such as anxiety, depression and phobias). During the clinical assessment and interviews, psychiatrists and geneticists did not notice any recognizable dysmorphic features in selected study subjects. DNA samples isolated from whole blood were genotyped with the Illumina HumanHap550 SNP array and 306 samples gave high quality data that were subjected to population structure and CNV analysis. See Table [1](#T1){ref-type="table"} for a summary of the genome-wide datasets used in this study.

###### 

Summary of datasets with whole-genome genotyping

  Dataset                             \#Subjects          \#Case   Platform         \#SNPs
  ------------------- --------------- ------------------- -------- ---------------- ---------
  **Croatia**         *(Before QC)*   306                 103      Illumina 550 K   561,466
                      *(After QC)*    305                 103                       489,200
  **NINDS**           *(Before QC)*   542                 0        Illumina 550 K   561,466
                      *(After QC)*    534                 0                         489,096
  **HGDP**            *(Before QC)*   1,043               0        Illumina 650Y    660,918
                      *(After QC)*    1,043               0                         584,835
                                                                                    
                                      *Merged datasets*                             
                                                                                    
  **Croatia+NINDS**   *(After QC)*    839                 103      \-               475,964
  **Croatia+HGDP**    *(After QC)*    1,348               103      \-               478,287

To understand the genetic homogeneity of the Croatian cohort and its position in the worldwide human population, we used phylogenetic tree analysis, principal component analysis (PCA) (not shown), and multi-dimensional scaling (MDS), three tools commonly used in the study of human population genetic diversity \[[@B23],[@B24]\]. We used data from the Human Genome Diversity Project (HGDP), which consists of genome-wide SNP data of 1007 individuals from 51 populations, divided into 7 geographic regions. Of these individuals, 153 were from 8 populations from the European region. We plotted the results of MDS and tree analyses using control subjects from Croatia and the HGDP samples (Figure [1](#F1){ref-type="fig"}). All three methods show the same overall pattern emerging from previous HGDP studies: the relative positions of the major regions largely correlate with their relative geographical locations, and reflect the human migration history well. Humans migrated from Africa to the Middle East (Figure [1A-B](#F1){ref-type="fig"}); the first branching took place, and one group migrated to Europe, while the other migrated to South Asia. A second major branching then occurred, with one migration to America (through Alaska), the other countinuing to East Asia and eventually Oceania. As expected, the Croatia control samples are entirely contained within the European samples. A focused analysis of Europeans in the HGDP panel (Figure [1C-D](#F1){ref-type="fig"}) with the Croatia control samples situated in the middle of phylogeny or MDS plots shows the relationship of this subpopulation to other European populations. The Sardinians and the Basques seem to be the farthest, with Italian samples placed in between them and the Croatian controls; the other subpopulation that is separate from the Croatia controls is the Adygei. The Croatians are most similar to the Russians and the Orcadians. Both the PCA (not shown) and MDS plots show the relative diversity of the Croatian controls (indicated by the area spanned by the samples on the MDS and PCA plots) to be similar to the other populations. The boxplot of pairwise Identity by State (IBS) distances for European populations (Figure [2A](#F2){ref-type="fig"}) showed the Croatian control cohort has divergence similar to other European subpopulations (except Basques and Sardinians who are genetically more homogeneous), and smaller than the European population as a whole.

![**Population structure of Croatia Cohort**. (A) FastME tree using IBS distance and (B) IBS distance multidimensional scaling (MDS) for Croatia control + HGDP, colored by HGDP region IDs. (C) FastME tree using IBS distance and (D) IBS distance multidimensional scaling (MDS) for Croatia Control + HGDP European Only, colored by HGDP subpopulation IDs.](1471-2350-11-134-1){#F1}

![**Pairwise IBS analysis**. (A) Box-and-whisker plot of pairwise IBS distances for Croatia Control, subpopulations of HGDP European Cohort, and the whole HGDP European Cohort. (B) Scatter plot of the first two coordinates of IBS distance multidimensional scaling (MDS) for Croatia control, case, and NINDS control cohorts.](1471-2350-11-134-2){#F2}

We performed MDS on the Croatian controls and cases, as well as NINDS (National Institute of Neurological Disorders and Stroke) control cohorts to check the relationships between the three cohorts (Figure [2B](#F2){ref-type="fig"}), and found that the Croatian control and cases are well mixed but separate from the NINDS controls. Randomization tests by shuffling between Croatian control and NINDS controls showed the median pairwise IBS (identity-by-state) distance across the two subsets (0.28) is significantly higher than expected by chance (p = 0.00273, see Figure [3](#F3){ref-type="fig"}); this agrees with the MDS visualization that the two cohorts are genetically separate. Analysis of fixation index (F~ST~) led to the same conclusion (see Table [2](#T2){ref-type="table"} for top regions with large F~ST~). In summary, the Croatian and the NINDS cohorts have significant genetic difference, and care must be taken to correct for population stratification in combining the two datasets for association studies.

![**Analysis of median and mean cross-population pairwise IBS distances between Croatia Control and NINDS**. (A) Observed median IBS distance and distribution of median IBS distances by random shuffling of population memberships; (B) observed mean IBS distance and distribution of median IBS distances by random shuffling of population memberships.](1471-2350-11-134-3){#F3}

###### 

Top windows for sliding window F~ST~analysis

  Cytoband            Coordinate            \#SNP   Mean Fst   Median Fst   Window/genomic ratio of Mean Fst   Window/genomic ratio of Median Fst
  ------------------- --------------------- ------- ---------- ------------ ---------------------------------- ------------------------------------
  1q23.2-1q23.3       chr1:157.5-162.5 Mb   1031    0.00170    0.00078      1.47                               1.51
  1q31.3              chr1:192.5-197.5 Mb   663     0.00186    0.00064      1.61                               1.23
  2q21.2-2q22.1       chr2:132.5-137.5 Mb   854     0.00242    0.00105      2.10                               2.02
  2q21.3-2q22.1       chr2:135-140 Mb       653     0.00233    0.00089      2.02                               1.71
  3q26.1-3q26.2       chr3:165-170 Mb       592     0.00185    0.00101      1.60                               1.95
  4q31.21-4q31.22     chr4:142.5-147.5 Mb   571     0.00236    0.00124      2.05                               2.38
  4q31.22-4q31.23     chr4:145-150 Mb       644     0.00187    0.00078      1.62                               1.51
  5q21.3-5q22.1       chr5:105-110 Mb       866     0.00167    0.00078      1.45                               1.51
  5q22.1-5q22.3       chr5:110-115 Mb       930     0.00155    0.00083      1.34                               1.59
  5q31.1-5q31.3       chr5:135-140 Mb       599     0.00220    0.00084      1.91                               1.62
  6p22.2-6p21.33      chr6:25-30 Mb         951     0.00182    0.00081      1.58                               1.56
  6p22.1-6p21.32      chr6:27.5-32.5 Mb     1339    0.00280    0.00140      2.42                               2.69
  6p21.33-6p21.31     chr6:30-35 Mb         1524    0.00285    0.00133      2.47                               2.57
  6p21.32-6p21.2      chr6:32.5-37.5 Mb     1096    0.00204    0.00084      1.77                               1.62
  6p12.1-6p11.1       chr6:55-60 Mb         440     0.00162    0.00079      1.40                               1.51
  6q11.1-6q12         chr6:62.5-67.5 Mb     618     0.00168    0.00094      1.45                               1.81
  6q16.3-6q21         chr6:100-105 Mb       748     0.00157    0.00085      1.36                               1.63
  7q31.32-7q32.1      chr7:122.5-127.5 Mb   776     0.00143    0.00084      1.24                               1.61
  8q21.13-8q21.3      chr8:82.5-87.5 Mb     590     0.00143    0.00083      1.24                               1.60
  8q21.2-8q21.3       chr8:85-90 Mb         626     0.00201    0.00098      1.74                               1.88
  9q12-9q21.11        chr9:67.5-72.5 Mb     414     0.00170    0.00088      1.48                               1.69
  9q33.2-9q33.3       chr9:122.5-127.5 Mb   681     0.00156    0.00080      1.35                               1.54
  9q33.2-9q34.11      chr9:125-130 Mb       804     0.00157    0.00079      1.36                               1.52
  11p11.2-11p11.12    chr11:45-50 Mb        443     0.00177    0.00062      1.54                               1.19
  11q13.1-11q13.3     chr11:65-70 Mb        597     0.00170    0.00083      1.48                               1.61
  12p11.1-12q12       chr12:35-40 Mb        540     0.00148    0.00100      1.28                               1.93
  13q31.1-13q31.3     chr13:85-90 Mb        688     0.00156    0.00085      1.35                               1.63
  20q11.21-20q11.23   chr20:30-35 Mb        461     0.00163    0.00093      1.41                               1.78
  22q13.1-22q13.2     chr22:37.5-42.5 Mb    757     0.00159    0.00080      1.38                               1.54

Mapping of large regions of homozygosity in pedigrees with shared ancestry has been employed in the discovery of autosomal recessive diseases associated with neurodevelopmental anomalies \[[@B31]-[@B33]\], and more recently, in the identification of novel genes associated with ASD, schizophrenia and Alzheimer\'s Disorder \[[@B17],[@B34],[@B35]\]. Although we recruited unrelated ASD cases and healthy controls, we analyzed genome-wide rates of homozygosity to estimate consanguinity and compared these rates to a heterogeneous control sample of Europeans from North America. It has been suggested that mapping of extended tracks of homozygosity may facilitate identification of low-frequency variants associated with complex diseases \[[@B36],[@B37]\]. We detected regions (\"runs\") of homozygosity (ROH) using the PLINK v1.05 software \[[@B38]\] and compared the extent of homozygosity in Croatia ASD cases, control subjects and NINDS controls. We computed the number of ROH segments, total ROH length, and average ROH length for the three subsets (Table [3](#T3){ref-type="table"}). We detected subtle differences between the three groups for the median number of ROHs (Kruskal-Wallis test; p = 0.06), as well as average ROH length between Croatia controls and NINDS controls (Wilcoxon test; p = 0.053), with NINDS cohort showing shorter total ROH length than Croatia controls (Kruskal-Wallis test; p = 0.0056, higher due to the very large number of NINDS samples). However, the most significant pairwise difference is the total ROH length between Croatian cases Croatian controls (Wilcoxon test; p = 0.0065).

###### 

Summary of the ROH comparison across Croatia Control, Croatia Case, and NINDS sample groups.

                                                          \#ROHs   Total ROH length(KB)   Average ROH length (KB)
  ------------------------------- ----------------------- -------- ---------------------- -------------------------
  *Median*                                                                                
                                                                                          
                                  Croatia Ctrl            15       23486.3                1512.2
                                  Croatia Case            16       26144                  1519.3
                                  NINDS                   16       23909.3                1476.3
                                                                                          
  *Wilcoxon Test P-value*                                                                 
                                                                                          
                                  Croatla Ctrl vs NINDS   0.0346   0.3928                 0.0529
                                  Croatla Case vs Ctrl    0.0413   **0.0065**             0.17
                                  Croatla Case vs NINDS   0.6115   0.0248                 **0.0037**
                                                                                          
  *Kruskal-Wallis Test P-value*                                                           
                                                                                          
                                  All three groups        0.0604   0.0279                 **0.0056**

Motivated by the study demonstrating the positive correlation between runs of homozygosity and age in a North American cohort of European descent due to urbanization \[[@B35]\], we examined age correlation with ROH frequency and size in the 103 ASD subjects (Figure [4](#F4){ref-type="fig"} and Table [4](#T4){ref-type="table"}). We found only borderline significance between age and average ROH size, though the lack of significance may be due to the fact that the Croatia ASD cohort is 40 years younger (mean age is 21.5 y as opposed to 61.7 y in Nalls et al. \[[@B35]\]).

![**Scatter plots for ROH number and length versus Age of Subject**. (A) Total ROH length (in Kb) versus Age; (B) Number of ROHs versus Age; (C) Average ROH size (in Kb) versus Age.](1471-2350-11-134-4){#F4}

###### 

Correlation between ROH and age

                                      No. ROH   Total ROH Size (Kb)   Average ROH Size (Kb)
  ------------------- --------------- --------- --------------------- -----------------------
  **(Intercept)**     *Coefficient*   17.8      35677.3               2009.64
                      *Coefficient*   -0.09     -328.5                -11.25
  **AGE**             *P-value*       *0.409*   *0.322*               *0.303*
                      *Coefficient*   -0.71     -12177.4              -605.62
  **SEX(male)**       *P-value*       *0.815*   *0.185*               ***0.0463***
                      *Coefficient*   0.087     564.4                 23.26
  **AGE:SEX(male)**   *P-value*       *0.467*   *0.119*               ***0.0517***

ROH regions were common or specific for a demographic group (Croatia vs. North America) or a disease status (ASD vs. controls). Although the longest ROH regions do not need to necessarily coincide with the disease susceptibility, we cannot exclude a possibility that recessive variants, such as single nucleotide or copy number variants within these regions contribute to disease susceptibility. To identify which regions contribute to the significant difference between Croatia case and control groups, we sorted the 7,740 endpoints of all autosomal ROHs across Croatia case and control groups, computed the significance of association between ROH status and case/control status by Fisher\'s test for each pair of adjacent ROH endpoints, and examined the significance of each such ROH interval where at least 5% (15) individuals have the ROH (Table [5](#T5){ref-type="table"}). The most significant ROHs are in two chromosomal regions: chr2:82,040,863-82,677,336 (2p12) and chr6:29,481,192-29,719,410 (6p21.1) (Figure [5](#F5){ref-type="fig"} and Figure [6](#F6){ref-type="fig"}). It is striking these two homozygosity regions are near several genes previously associated with neurological and psychiatric disorders. The chromosome 2 interval (636 Kb) is located downstream of *CTNNA2*(alpha catenin) and *LRRTM1*(leucine-rich repeat transmembrane neuronal protein 1), and contains a segment (between SNPs rs2685729 and rs2862972) significantly enriched in ASD subjects (top p = 2.5 × 10^-3^). The *LRRTM1*gene is associated with left-handedness (patients with autism and many other psychiatric disorders have a higher tendency to be left-handed \[[@B39]\]) and may increase risk of schizophrenia \[[@B40],[@B41]\]. The chromosome 6 interval (238 Kb) is a gene-rich region located distal to the major histocompatibility complex. This ROH is shared by 17 ASD subjects (16.5%) and 19 controls (9.6%) spans 8 genes, including a cluster of olfactory receptors (*OR11A1*, *OR10C1*, *OR2H1*, *OR2H2*), the *MOG*locus, and the *GABBR1*locus. The *MOG*gene (myelin oligodendrocyte glycoprotein) is a transmembrane protein expressed on the surface of myelin sheath, and may be involved in multiple sclerosis (OMIM\#126200) \[[@B42],[@B43]\]; recent studies also found that *MOG*is differentially expressed in prefrontal cortex and temporal lobes in schizophrenic patients \[[@B43],[@B44]\]. The most significant interval (between SNPs rs1233399 and rs29225; top p = 3.4 × 10^-3^) spans the 3\' end of the *GABBR1*(Gamma-aminobutyric acid (GABA) B receptor, 1) and the overlapping *UBD*(Ubiquitin D) loci. *GABBR1*is highly expressed in nervous systems and has been suggested as a candidate region for neuropsychiatric disorders \[[@B45],[@B46]\]. A recent study showed that the expression levels of GABBR1 are significantly lower in several brain regions in patients with autism compared with healthy controls \[[@B47]\]. Finally, we examined the median IBS distances between the subjects with regions of homozygosity on chromosomes 2 (13 Croatian cases and 10 Croatian controls) and chromosome 6 (17 Croatian cases and 19 Croatian controls) with permutation tests, but found that these subjects were not more closely related than the population average. Thus, the increased homozygosity in Croatia ASD cases cannot be explained by inbreeding among close relatives in a small number of selected families. However, the observed homozygosity may be the result of shared ancestral alleles from generations back in time.

###### 

Top ROH regions in ROH association analysis

  CHR   START       END         SIZE (KB)   \#SNPs   \#ROH&Case   \#Case   \#ROH&Ctrl   \#Ctrl   \#ROH   \#Samples   OR     P
  ----- ----------- ----------- ----------- -------- ------------ -------- ------------ -------- ------- ----------- ------ ------------
  2     82040863    82067472    26610       3        11           103      8            198      19      301         2.83   0.0424
  2     82067472    82143271    75800       11       11           103      7            198      18      301         3.25   0.0195
  2     82143271    82146419    3149        3        12           103      7            198      19      301         3.58   0.0105
  2     82146419    82235100    88682       18       12           103      8            198      20      301         3.12   0.0153
  2     82235100    82276290    41191       6        12           103      9            198      21      301         2.76   0.0305
  2     82276290    82330384    54095       4        12           103      8            198      20      301         3.12   0.0153
  2     82330384    82342863    12480       2        13           103      8            198      21      301         3.42   **0.0081**
  2     82342863    82367354    24492       7        12           103      8            198      20      301         3.12   0.0153
  2     82367354    82677336    309983      20       12           103      7            198      19      301         3.58   0.0105
  2     82677336    82706135    28800       3        12           103      5            198      17      301         5.06   **0.0025**
  2     135475565   135478814   3250        2        4            103      21           198      25      301         0.34   0.0488
                                                                                                                            
  4     34049422    34100634    51213       8        30           103      37           198      67      301         1.78   0.0421
  4     34100634    34156199    55566       7        30           103      36           198      66      301         1.85   0.0393
  4     34156199    34179397    23199       5        29           103      35           198      64      301         1.82   0.0386
  4     34378375    34397251    18877       3        26           103      30           198      56      301         1.89   0.0420
  4     34531827    34538866    7040        2        17           103      16           198      33      301         2.24   0.0326
                                                                                                                            
  5     42508871    42588188    79318       9        11           103      8            198      19      301         2.83   0.0424
                                                                                                                            
  6     29481192    29574935    93744       17       16           103      15           198      31      301         2.24   0.0442
  6     29574935    29591890    16956       7        16           103      14           198      30      301         2.41   0.0255
  6     29591890    29602876    10987       3        15           103      13           198      28      301         2.42   0.0348
  6     29602876    29607484    4609        2        15           103      11           198      26      301         2.89   0.0156
  6     29607484    29623781    16298       3        16           103      11           198      27      301         3.11   **0.0056**
  6     29623781    29638829    15049       5        16           103      10           198      26      301         3.44   **0.0040**
  6     29638829    29639232    404         3        15           103      9            198      24      301         3.56   **0.0034**
  6     29639232    29641274    2043        2        14           103      9            198      23      301         3.29   0.0101
  6     29641274    29645954    4681        4        14           103      10           198      24      301         2.95   0.0131
  6     29645954    29647461    1508        2        14           103      9            198      23      301         3.29   0.0101
  6     29647461    29666169    18709       6        14           103      8            198      22      301         3.72   **0.0042**
  6     29666169    29689020    22852       11       13           103      8            198      21      301         3.42   **0.0081**
  6     29689020    29716673    27654       2        12           103      7            198      19      301         3.58   0.0105
  6     29716673    29719410    2738        2        11           103      7            198      18      301         3.25   0.0195
  6     29719410    29723801    4392        3        10           103      7            198      17      301         2.92   0.0356
  6     61949597    62025463    75867       2        11           103      7            198      18      301         3.25   0.0195
  6     62030461    62041958    11498       4        12           103      9            198      21      301         2.76   0.0305
                                                                                                                            
  7     69474084    69475255    1172        2        2            103      16           198      18      301         0.23   0.0392
                                                                                                                            
  8     51323785    51339189    15405       2        7            103      30           198      37      301         0.41   0.0416
                                                                                                                            
  12    33162179    33170263    8085        2        10           103      6            198      16      301         3.43   0.0266
  12    33170263    33329348    159086      27       10           103      7            198      17      301         2.92   0.0356
  12    33329348    33331881    2534        2        11           103      7            198      18      301         3.25   0.0195
  12    33331881    33335472    3592        2        12           103      8            198      20      301         3.12   0.0153
  12    33335472    33349548    14077       2        13           103      11           198      24      301         2.45   0.0426
  12    49797511    49861882    64372       6        10           103      7            198      17      301         2.92   0.0356

![**UCSC Genome Browser genomic annotation around the region chr2:82,040,863-82,677,336**. Genomic annotations of a region where ROH status is associated with case/control status in the Croatia cohort.](1471-2350-11-134-5){#F5}

![**UCSC Genome Browser genomic annotation around the region chr6:29,481,192-29,719,410**. Genomic annotations of a region where ROH status is associated with case/control status in the Croatia cohort.](1471-2350-11-134-6){#F6}

Several studies have shown a role for copy number variation in predisposing individuals to complex diseases \[[@B48]\], including ASD \[[@B15],[@B49]-[@B52]\]. To address this, we next analyzed CNV calls from the high-density SNP genotyping data in Croatia cases and control subjects. We used PennCNV \[[@B53]\], a high-resolution CNV detection method, to call CNVs from the signal intensity data. We identified 2,303 CNVs (using a 10-SNP threshold) in 304 subjects passing the quality control criteria (Table [6](#T6){ref-type="table"}). The median size of CNVs is 71.4 Kb, while the mean size of CNVs is 131.4 Kb. Due to the relatively small sample size, we do not expect that we could detect association of specific CNVs with disease status; instead, we focused on large and rare CNVs observed in cases but not controls, since they are more likely to be disease-related. For example, a recent study identified large (\>500 Kb) CNVs to be especially pathogenic \[[@B54]\]; in addition, a CNV study on schizophrenia demonstrates that CNVs \>500 Kb tend to be more prevalent in cases versus controls \[[@B55]-[@B57]\], and that CNVs \>2 Mb are observed exclusively in cases \[[@B15],[@B16]\].

###### 

Summary of the CNV analysis.

  CNV size   Croatian ASD (n = 103)                  Croatian controls (n = 197)                                                                               
  ---------- ------------------------ ---------- --- ----------------------------- --- --------- ---- --------- --- --------- --- --------- ---- --------- --- ---------
  \>500 Kb   14                       (13.59%)   7   (6.80%)                       7   (6.80%)   18   (9.14%)   1   (0.51%)   4   (2.03%)   12   (6.09%)   1   (0.51%)
  \>1 Mb     8                        (7.77%)    4   (3.88%)                       4   (3.88%)   8    (4.06%)   0   (0.00%)   3   (1.52%)   4    (2.03%)   1   (0.51%)
  \>2 Mb     5                        (4.85%)    2   (1.94%)                       3   (2.91%)   1    (0.51%)   0   (0.00%)   0   (0.00%)   1    (0.51%)   0   (0.00%)

Examining 299 unrelated individuals passing QC, we identified a total of 32 CNVs \>500 Kb, including 20 duplications and 12 deletions (Table [7](#T7){ref-type="table"} and Table [8](#T8){ref-type="table"}). These large chromosomal rearrangements, detected in DNA samples isolated from blood (rather then cell lines), were confirmed through signal intensity data for the entire chromosome in the Illumina BeadStudio software (data not shown). Among them, 5/103 cases (4.85%) and 1/197 controls subject (0.49%) have CNVs greater than 2 Mb. An exceptionally large CNV was detected in an ASD female that harbored an 18 Mb duplication on chromosome 7 (7q21.11-21.3), which includes several known neurodevelopmental genes (*PCLO*, *SEMA3A*, *SEMA3C*, *SEMA3D*and *SEMA3E*). A duplication of this chromosomal region has been associated with intellectual disability and multiple congenital anomalies \[[@B58]\]. Another female has a 10 Mb deletion on chromosome 11 (11q24.2-q25). The Jacobsen syndrome (MIM147791) is a contiguous gene syndrome caused by terminal deletions of the long arm of chromosome 11 and typically associated with growth and psychomotor retardation and characteristic facial dimorphism \[[@B59]\].

###### 

Large CNVs in the Croatia dataset: CNVs longer than 500 Kb in Croatia Cases.

  Chromosomal Region (Cytogenetic Coordinate)   **Copy No**.   Length (Kb)   No. SNPs   Start SNP    End SNP      Genes                                                                                                                                                                                                                                                                                                  Individual   Sex   Age
  --------------------------------------------- -------------- ------------- ---------- ------------ ------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------ ----- -----
  chr1:144943150-145824905 (1q21.1)             3              882           207        rs6656361    rs11240147   ACP6, BCL9, CHD1L, FMO5, GJA5, PRKAB2                                                                                                                                                                                                                                                                  AC0037       m     31
  chr2:129716352-130250751 (2q21.1)             1              534           114        rs1251175    rs7578253    HS6ST1 (923711 bp upstream); RAB6C (202954 bp downstream)                                                                                                                                                                                                                                              AC0068       m     9
  chr2:199943597-201740672 (2q33.1)             1              1,797         324        rs13028839   rs10200857   AOX1, BZW1, C2orf47, C2orf60, CFLAR, CLK1, FAM126B, FLJ38973, KCTD18, LOC26010, NDUFB3, NIF3L1, ORC2L, PPIL3, SATB2, SGOL2                                                                                                                                                                             AC0086       m     11
  chr4:189924391-191164126 (4q35.2)             1              1,240         174        rs4863387    rs13120250   FRG1, TUBB4Q                                                                                                                                                                                                                                                                                           AC0025       m     22
  chr7:124752465-125591197 (7q31.33)            1              839           132        rs7810309    rs510319     POT1 (395192 bp upstream); GRM8 (274696 bp downstream)                                                                                                                                                                                                                                                 AC0058       f     35
  chr7:78246495-97499079 (7q21.11-21.3)         3              18,681        3381       rs13308578   rs6960808    ABCB1, ABCB4, ADAM22, C7orf23, CACNA2D1, CD36, CROT, DBF4, DMTF1, GNAI1, GNAT3, GRM3, HGF, KIAA1324L, MAGI2, MGC26647, PCLO, RUNDC3B, SEMA3A, SEMA3C, SEMA3D, SEMA3E, SLC25A40, SRI, STEAP4, ZNF804BCLDN12, FLJ21062, GTPBP10, PFTK1, STEAP1, STEAP2, ZNF804BACN9, AKAP9, ANKIB1, ASB4, ASNS, BET1     AC0015       m     20
  chr10:41756307-42461241 (10q11.1-11.21)       3              705           49         rs10909011   rs158389     ZNF33B                                                                                                                                                                                                                                                                                                 AC0061       m     17
  chr10:54450683-58765948 (10q21.1)             1              4,315         951        rs2249349    rs2928464    PCDH15, ZWINT                                                                                                                                                                                                                                                                                          AC0045       m     33
  chr11:124367724-134445626 (11q24.2-q25)       1              10,078        2842       rs6590113    rs11224228   ACAD8, ACRV1, ADAMTS15, ADAMTS8, APLP2, B3GAT1, BARX2, C11orf38, C11orf45, CCDC15, CDON, CHEK1, DCPS, DDX25, EI24, ETS1, FAM118B, FEZ1, FLI1, FOXRED1, GLB1L3, HNT, HYLS1, IGSF9B, JAM3, KCNJ1, KCNJ5, KIRREL3, LOC219854, LOC89944, NCAPD3, NFRKB, OPCML, P53AIP1, PATE, PKNOX2, PRDM10, PUS3, RICS   AC0052       f     26
  chr12:37835456-42584684 (12q12)               3              4,538         976        rs11170890   rs4488262    ABCD2, C12orf40, KIF21A, LRRK2, SLC2A13CNTN1ADAMTS20, GLT8D3, IRAK4, PDZRN4, PPHLN1, PRICKLE1, PUS7L, TMEM117, TWF1, YAF2, ZCRB1                                                                                                                                                                       AC0093       m     17
  chr16:15032942-16197033 (16p13.11)            3              1,164         201        rs4985124    rs8056397    ABCC1, ABCC6, C16orf45, C16orf63, KIAA0430, MPV17L, MYH11, NDE1, NTAN1, PDXDC1, RRN3                                                                                                                                                                                                                   AC0003       m     31
  chr16:21482719-29234430 (16p12.2-11.2)        3              7,175         1266       rs13339281   rs7500911    C16orf65, CDR2, CHP2, COG7, DCTN5, EARS2, EEF2K, ERN2, GGA2, HS3ST2, IGSF6, LOC23117, METTL9, NDUFAB1, OTOA, PALB2, PLK1, POLR3E, PRKCB1, SCNN1B, SCNN1G, UBFD1, UQCRC2, USP31, VWA3ACACNG3, PRKCB1, RBBP6AQP8, ARHGAP17, LCMT1, SLC5A11, ZKSCAN2HS3ST4APOB48R, ATP2A1, ATXN2L, C16orf82, CCDC101      AC0088       m     15
  chr17:28980655-29960126 (17q12)               3              979           350        rs11657037   rs11657603   ACCN1, CCL1, CCL11, CCL13, CCL2, CCL7, CCL8, FLJ44815, TMEM132E                                                                                                                                                                                                                                        AC0100       m     13
  chr22:48833840-49524956 (22q13.33)            1              691           126        rs137916     rs2285395    ACR, ADM2, ARSA, CHKB, CPT1B, ECGF1, FAM116B, HDAC10, KLHDC7B, LOC164714, LOC440836, MAPK11, MAPK12, MAPK8IP2, MIOX, MLC1, MOV10L1, NCAPH2, PANX2, PLXNB2, SAPS2, SBF1, SCO2, SELO, SHANK3, TMEM112B, TRABD, TUBGCP6                                                                                   AC0058       f     35

###### 

Large CNVs in the Croatia dataset: CNVs longer than 500 Kb in Croatia Controls.

  Chromosomal Region (Cytogenetic Coordinate)   **Copy No**.   Length (Kb)   No. SNPs   Start SNP    End SNP      Genes                                                                                                                                                                                                                                                                            Individual   Sex   Age
  --------------------------------------------- -------------- ------------- ---------- ------------ ------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------ ----- -----
  chr2:836164-1827317 (2p25.3)                  3              991           202        rs4533500    rs11127313   LOC391343, MYT1L, PXDN, SNTG2, TPO                                                                                                                                                                                                                                               Aut_26       m     28
  chr3:186745-1313259 (3p26.3)                  3              1,127         339        rs6442427    rs1353825    CHL1, CNTN6                                                                                                                                                                                                                                                                      Aut_46       f     36
  chr3:57010-1122201 (3p26.3)                   3              1,065         267        rs1516321    rs6797539    CHL1, CNTN6                                                                                                                                                                                                                                                                      Aut_99       m     14
  chr4:188763338-190322725 (4q35.2)             1              1,559         333        rs13147499   rs13106777   FLJ25801, TRIML1, ZFP42                                                                                                                                                                                                                                                          Aut_37       m     27
  chr4:190385789-190982886 (4q35.2)             3              597           69         rs10446846   rs6844114    TRIML1 (1080146 upstream); FRG1 (116082 downstream)                                                                                                                                                                                                                              Aut_141      m     20
  chr5:104486852-105008254 (5q21.2-21.3)        3              521           58         rs294152     rs6872786    NUDT12 (1560463 upstream); EFNA5 (1735996 downstream)                                                                                                                                                                                                                            Aut_36       f     29
  chr7:49000866-49879997 (7p12.3-12.2)          3              879           165        rs1004168    rs6963083    VWC2                                                                                                                                                                                                                                                                             Aut_203      f     20
  chr7:79347222-81014740 (7q21.11)              1              1,668         336        rs6949571    rs2909580    CD36, GNAI1, GNAT3, SEMA3C                                                                                                                                                                                                                                                       Aut_65       m     8
  chr8:4005541-4886423 (8p23.2)                 1              881           781        rs7006672    rs7815159    CSMD1                                                                                                                                                                                                                                                                            Aut_38       f     25
  chr8:85925158-87860757 (8q21.2-21.3)          1              1,936         257        rs4740033    rs11781187   ATP6V0D2, C8orf59, CA1, CA13, CA2, CA3, CNGB3, CPNE3, E2F5, FAM82B, LRRCC1, PSKH2, RALYL, REXO1L1, SLC7A13, WWP1                                                                                                                                                                 Aut_114      f     29
  chr9:22934927-23536461 (9p21.3)               3              602           136        rs1463014    rs7028484    DMRTA1 (492455 upstream); ELAVL2 (143644 downstream)                                                                                                                                                                                                                             Aut_54       m     27
  chr12:33415349-34701470 (12p11.1)             4              1,286         104        rs1905414    rs9706509    ALG10, SYT10                                                                                                                                                                                                                                                                     Aut_39       m     23
  chr15:70783089-73316235 (15q24.1-24.2)        3              2,533         382        rs11072382   rs1565496    ADPGK, ARID3B, BBS4, C15orf17, C15orf39, CCDC33, CD276, CLK3, COX5A, CPLX3, CSK, CYP11A1, CYP1A1, CYP1A2, EDC3, GOLGA6, HCN4, ISLR, ISLR2, LMAN1L, LOC283677, LOC388135, LOXL1, MPI, NEO1, NPTN, PML, PPCDC, RPP25, SCAMP2, SCAMP5, SEMA7A, STOML1, STRA6, TBC1D21, UBL7, ULK3   Aut_10       m     48
  chr16:76525505-77164850 (16q23.1)             3              639           235        rs387138     rs2346008    CLEC3A, KIAA1576, WWOX                                                                                                                                                                                                                                                           Aut_148      m     38
  chr22:17690812-18613429 (22q11.21)            3              923           248        rs982520     rs854971     ARVCF, C22orf25, C22orf29, CDC45L, CLDN5, COMT, DGCR8, GNB1L, GP1BB, HIRA, HTF9C, LOC128977, MRPL40, RANBP1, RTN4R, SEPT5, TBX1, TXNRD2, UFD1L, ZDHHC8                                                                                                                           Aut_94       m     6
  chr22:19102598-19665559 (22q11.21)            3              563           97         rs738089     rs7292968    AIFM3, CRKL, KLHL22, MED15, PI4KA, SCARF2, SERPIND1, SNAP29                                                                                                                                                                                                                      Aut_94       m     6
  chrX:6468166-8112188 (Xp22.31)                3              1,644         190        rs6654819    rs2278935    HDHD1A, PNPLA4, STS, VCX, VCX2                                                                                                                                                                                                                                                   Aut_157      f     41
  chrX:93063380-93732495 (Xq21.32-21.33)        0              669           88         rs6615574    rs5950049    FAM133A (209463 upstream); DIAPH2 (2093870 downstream)                                                                                                                                                                                                                           Aut_155      m     38

Three of the ASD cases have multiple large rearrangements; one adult male harbors two chromosomal rearrangements (separated by 117 Mb) on chromosome 1, a 335 Kb deletion on 1p35.3 and a 882 Kb duplication on 1q21.1 (Figure [7a](#F7){ref-type="fig"}). In a second individual (adult female) we identified two distinct large CNVs: a 838 Kb deletion in an intergenic region between *GRM8*and *POT1*on 7q31.33 (chr7:124,752,465-125,591,197) and a 691 Kb deletion at 22q13.33 (chr22:48,833,840-49,524,956). This deletion encompasses the *SHANK3*gene and cytogenetic rearrangements affecting this gene have been previously associated with ASD \[[@B60],[@B61]\]. It has been previously reported that the 22q13 deletion syndrome, also known as Phelan-McDermid syndrome (MIM606232), is characterized by severe neonatal hypotonia and global developmental delay, normal to accelerated growth, absent to severely delayed speech, and minor dysmorphic features \[[@B62],[@B63]\]. The third individual (male child) with multiple large rearrangements harbors a 534 Kb intergenic deletion at 2q21.1 (chr2: 129,716,352-130,250,751) and a 400 Kb duplication at 3q29 (chr3:195,987,870-196,387,903). These large structural variants, especially those found on multiple chromosomes illustrate the need to combine high-density genotype analysis with karyotype analysis to test for the presence of balanced translocations and inversions.

![**CNV status of AGRE, NINDS control, and Croatia ASD/control cohorts**. (A) CNVs around four candidate genes (*ACP6*, *CHD1L*, *FMO5*, and *PRKAB2)*in 882 kb duplication on 1q21.1 (chr1:144,943,150-145,824,905). (B) Duplication of size 979 kb around the neuronal amiloride-sensitive cation channel gene (*ACCN1)*on Chr 17q11.2-q12 (chr17:28,000,000-30,100,000).](1471-2350-11-134-7){#F7}

In contrast to large rearrangements encompassing \>10 Mbs that were observed in ASD cases, the largest rearrangement observed in control subjects is a 2.5 Mb duplication at 15q24.1-q24.2 (chr15:70,783,089-73,316,235), a known microdeletion/duplication region \[[@B64]\]. Also, we found one control subject to have two duplications within the DiGeorge (MIM188400) and Velocardiofacial (MIM192430) syndrome region on chromosome 22 (22q11.21), a known pathogenic rearrangement hotspot where large (\>1.5 Mb) deletions are pathogenic \[[@B65]\]. These duplications (922 Kb in chr22:17,690,812-18,613,429 and 563 Kb in chr22:19,102,598-19,665,559) are separated by 489 Kb. The observation that we see more large CNVs associated with ASD subjects (\>2 Mb: 5 cases, 1 control; Fisher\'s test; p = 0.019) suggests these large rearrangements may be rare ASD susceptible variants; follow-up investigations on larger cohorts will be necessary.

Conclusions
===========

In this paper, we report analysis of a genome-wide high-density genotype study for ASD in Croatia. The dataset, although small, provides a distinctive opportunity to evaluate structural variation associated with a complex disease such as ASD in a genetically distinct population. In addition to the analysis of ASD, high-density genotype data from a well-defined geographic area of Croatia permitted also the study of the subjects\' genetic substructure and diversity. We asked whether the subjects included in this study which were collected throughout Croatia, show a lower level of genomic diversity in comparison to subjects from other defined demographic areas. Addressing this issue may suggest that a set of 100 Croatian ASD subjects harbor a smaller set of susceptibility loci in comparison a randomly selected set of ASD subjects from a larger area. The Croatian samples represent a genetic continuum of relatedness with a subset of individuals closer to those from several regions in Europe, probably due to numerous historic migrations. The impact of fine-scale population history on the genetic substructure of individuals from Croatia has recently been evaluated using a small set of selected loci \[[@B21]\]. To our knowledge, this study is the first to provide a genome-wide view of the genetic composition of the Croatia population.

Although our study represents the first high-resolution genomic analysis of subjects with ASD in Croatia, several caveats need to be addressed. Apart from an obviously limited sample size, the classification of ASD subjects in this pilot project has been established using the DSM-IV criteria. Due to phenotypic heterogeneity of ASD and our finding of a wide-range of novel, and in some cases, exceptionally large CNVs, there is a need for accurate clinical diagnostic criteria for the diagnosis of ASD and related neurodevelopmental syndromes. Currently no other diagnostic tools were available in Croatian; in order to compare our findings to those in other large-scale genetic studies it will be necessary to translate gold standard diagnostic tools such as ADOS \[[@B66]\] and ADI-R \[[@B67]\] to Croatian and many other languages.

We used PennCNV to call copy number variations, though other CNV calling programs such as QuantiSNP \[[@B68]\] and cnvPartition (a built-in software tool in the Illumina BeadStudio software)are available An advantage of using multiple CNV calling programs is to reduce false positives, namely one can focus on CNVs returned by multiple programs and expect them to be \"more reliable\". Since our study focused on large CNVs (\>500 Kb) we were able to validate these variants by visual inspection of the raw intensities(data not shown).

We found that runs of homozygosity are more frequent in Croatia ASD subjects than either Croatia or NINDS control cohorts. Given the low frequency of subjects with ROH, larger follow-up studies are necessary to confirm the findings. Our findings suggest there is a high chance that homozygosity mapping based on family studies can discover rare recessive variants. Our finding that several ASD subjects harbor exceptionally large chromosomal rearrangements previously associated with distinct clinical syndromes such as Velocardiofacial, Jacobsen, Phelan-McDermid, or 3q29 microdeletion/duplication syndromes (MIM609425; MIM611936) lends support for cytogenetic or high-density genotype testing for ASD subjects with complex clinical manifestation \[[@B69]\]. Furthermore, recent findings that seemingly diverse neurodevelopmental and neurological disorders are often associated with the same chromosomal rearrangement(s) provide support for in-depth phenotype analysis and longitudinal clinical evaluation of entire families. These family-based studies may also reveal whether observed structural variants are *de novo*events or rather inherited and present in additional family members. We suggest that deeper population screens combined with family-based genetic analyses will lead to improved understanding of joint actions of associated loci and molecular basis of neurodevelopmental disorders in populations worldwide.

Methods
=======

Subjects and DNA Preparation
----------------------------

The patient group consisted of 103 individuals (81 male, 22 female, mean age 21.5 ± 10.3, ranging from 4 to 45) recruited from the Centers for Autism in Zagreb, Rijeka and Split (Republic of Croatia) and diagnosed with autism spectrum disorders according to DSM-IV criteria. The control group consisted of 203 healthy blood donors (146 male, 57 female, mean age 32.5 ± 8.06, ranging from 19 to 45) \[[@B30]\] with no history of mental illnesses, behavioral disorders, or substance abuse. All subjects were of Croatian (southern Slavic) origin. After an informative talk, a written consent for inclusion in the study was obtained from the control subjects and from the patients\' parents. The study has been carried out in accord with the Declaration of Helsinki, and was approved by the Ethics Committee of the Medical Faculty of the University of Zagreb.

Blood sampling was performed in the Centers for Autism (ASD cases) and in the Croatian Institute of Transfusion Medicine (control subjects) between 9 and 11 a.m. Either 2 or 5 ml of venous blood, depending on the age of the participants, was collected into vacutainers containing EDTA anticoagulant. DNA was isolated from the whole blood using a DNA isolation kit for mammalian blood (Boehringer Manheim, Germany).

Datasets and Preprocessing
--------------------------

The genomic DNA from blood was used to obtain genotypes by the Illumina HumanHap550 version 3 high-density array with 561,446 SNP markers. Coordinates of SNPs as well as genomic annotations are based on NCBI human genome build 36.3, (UCSC Genome Browser Release 18). The genotyping experiments were performed at the Center for Applied Genomics, Children\'s Hospital of Philadelphia, as previously described \[[@B70]\]. The raw genotyping signal data were processed by the Illumina BeadStudio software and converted to normalized signal intensity values, represented as Log R Ratio (LRR) and B Allele Frequency (BAF). Due to the presence of \"genomic wave patterns\" in some of the genotyped samples, we applied a data pre-processing protocol \[[@B71]\] to increase the signal-to-noise ratio of the LRR values for all samples.

We analyzed three genome-wide datasets: Croatia Autism cohort (306 subjects), NINDS Control cohort (542 subjects), and genotyping data from the Human Genetic Diversity Panel (1043 subjects, genotyped at Stanford University, downloaded from <http://hagsc.org/hgdp/files.html>). The quality control (QC) procedure (described in detail in Wang et al. \[[@B14]\] and Bucan et al. \[[@B16]\]), done separately for the three datasets, is as follows: (1) we first discarded SNPs with 5% or more missing genotyping calls; (2) we then recomputed summary statistics for individuals and markers; (3) we retained individuals/markers passing the following threshold: individual - missing genotyping call percentage ≤5%; marker - missing genotyping call percentage ≤5%, minor allele frequency ≥5%. We then merged the Croatia cohort with the NINDS control and HGDP datasets separately into two combined datasets (Croatia samples and HGDP, Croatia samples and NINDS), including all individuals passing QC in their separate datasets, and retaining only markers passing QC in both datasets. Subpopulation membership for HGDP samples were obtained from Supplemental material from Kidd et al. \[[@B72]\]

To detect hidden related samples, we computed $\overset{\land}{\pi}$, the estimated probability of IBD between every pair of subjects from the Croatia control and case and NINDS control samples using PLINK. We found 5 pairs of Croatia control samples (but none among the case samples) and 4 pairs of NINDS control samples have $\overset{\land}{\pi}$ \> 0.25 (siblings or closer). To be more specific, three Croatia control pairs and one NINDS control pair have $\overset{\land}{\pi}$ \> 0.999 (duplicate genotyping or monozygotic twins), and two Croatia Ctrl pairs and three NINDS control pairs have $\overset{\land}{\pi}$ around 0.5 (first-degree relatives). To reduce relatedness, in subsequent analysis, for each pair we removed the one of the two samples with a larger index number in the ROH analysis. Table [1](#T1){ref-type="table"} summarizes the three genome-wide datasets analyzed in this paper.

IBS distance analysis
---------------------

We computed the IBS (identity by state) distance between any two subjects using PLINK, and constructed three pairwise distance matrices: Croatia controls and HGDP, Croatia controls and NINDS, Croatia cases and controls. The IBS distance between two subjects is defined as A+B/2, where A and B are the number of SNPs that differ by one and two alleles between the two subjects, respectively. We performed multidimensional scaling using R \[[@B73]\] and plotted the first two coordinates, and built trees using FastME, a distance-based phylogeny reconstruction software \[[@B74]\].

F~ST~Analysis
-------------

To quantitatively describe the genetic difference between two population we next used the F~ST~coefficient (fixation coefficient). This measure combines information across many loci in many individuals and a higher F~ST~value for a locus indicates difference between the genetic compositions in two populations, whereas F~ST~= 0 implies no discernable difference between two populations at the locus.

We analyzed the F~ST~values using the Croatia control and NINDS control cohorts as follows. We first computed the heterozygosity of each marker (defined as the proportion of heterozygous individuals in the population) using PLINK, then computed the fixation index *F*~*ST*~from the heterozygosity by R by the following steps. (1) Compute the minor allele frequencies p~1~, p~2~and p for the two subpopulations (with N~1~and N~2~subjects) and the whole population (with N = N~1~+ N~2~subjects). (2) Compute the expected proportion of heterozygotes H~T~= p (1-p) assuming the two subpopulations are genetically identical for the marker. (2) Compute the expected proportion of heterozygotes H~S~= (N~1~p~1~(1-p~1~) + N~2~p~2~(1-p~2~))/N. (3) Compute $F_{ST} = 1 - \frac{H_{S}}{H_{T}}$.

Runs of homozygosity
--------------------

Runs of homozygosity (ROHs) are extended genomic regions where the DNA sequences on the two chromosomes are identical, and may be due to identity by descent or gene conversion; since polymorphic sites are all homozygous, SNP arrays can be used to identify such regions. Study of ROHs can provide information on the population structure such as extent of inbreeding, and can be used to find candidate genes in recessive disorders. We computed the distribution of runs of homozygosity for three groups (Croatia case, control, NINDS) using PLINK with the following settings: an interval passes as an ROH if it has 100 or more homozygous SNPs (except at most one SNP), with density at least one SNP every 50 Kb and at most 1 Kb gap between any two neighboring SNPs. We ran Wilcoxon test between every pair of the three groups, as well as Kruskal-Wallis test for comparing three groups simultaneously.

To identify genomic regions where the ROH status correlates with the case/control status, we ran Fisher\'s test as follows: we first sorted the 7,766 endpoints of all autosomal ROHs across Croatia case and control groups; for each pair of adjacent endpoints, we computed the significance of association between ROH status and case/control status by Fisher\'s test.

Correlation between ROH and age
-------------------------------

Motivated by the study demonstrating the positive correlation between runs of homozygosity and age in a North American cohort of European descent due to urbanization \[[@B35]\], we examined the correlation between age and ROH frequency and size. Only the 103 ASD subjects have age information. We used age and sex as covariates in a full linear regression model (in R/S-Plus specification):

$$\left. \text{Y} \right.\sim\text{AGE}*\text{SEX}$$

Here the dependent variable can be either the total ROH length, average ROH length, or number of ROH regions in a subject.

CNVs analysis
-------------

A previously described high-resolution CNV detection algorithm, the PennCNV algorithm \[[@B53]\], was used to infer CNVs from the signal intensity data following protocols described in Wang et al. \[[@B53]\] The PennCNV algorithm uses a Hidden Markov model to identify any genomic regions with duplications or deletions by combining signal intensity and SNP allelic ratio distributions. The Illumina BeadStudio software provided visualization tools that were used to display signal intensity data for the entire chromosome.
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